Bortezomib in the Treatment of Multiple Myeloma
Produktform: E-Buch Text Elektronisches Buch in proprietärem
Multiple Myeloma (MM) is the second most-common blood cancer. Bortezomib is a promising anticancer-drug targeting the proteasome. This monograph on bortezomib is a valuable source of information for researchers and clinicians from oncology and pharmacology.
96,29 € inkl. MwSt.
Recommended Retail Price
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage
Bortezomib in the Treatment of Multiple Myeloma
Produktform: Buch / Einband - fest (Hardcover)
Multiple Myeloma (MM) is the second most-common blood cancer. Bortezomib is a promising anticancer-drug targeting the proteasome. This monograph on bortezomib is a valuable source of information for researchers and clinicians from oncology and pharmacology.
106,99 € inkl. MwSt.
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage